Back معهد أبحاث السرطان (لندن) Arabic Institute of Cancer Research Catalan Institute of Cancer Research Spanish مؤسسه تحقیقات سرطان Persian Institute of Cancer Research French Institute of Cancer Research Hungarian ロンドン大学癌研究所 Japanese Institute of Cancer Research NB انسٹی ٹیوٹ آف کینسر ریسرچ Urdu 癌症研究院 Chinese
 | |
| Type | Public |
|---|---|
| Established | 1909[1] |
Parent institution | University of London |
| Endowment | £2.07 million (2023)[2] |
| Budget | £138.7 million (2022/23)[2] |
| Chairman | Julia Buckingham[3] |
| Chancellor | The Princess Royal (University of London) |
| Chief Executive | Kristian Helin[4] |
Academic staff | 895 (2022/23)[2] |
Administrative staff | 275 (2022/23)[2] |
| Students | 280 (2019/20)[5] |
| Postgraduates | 280 (2019/20)[5] |
| Location | , |
| Campus | Urban |
| Website | icr |
The Institute of Cancer Research (the ICR) is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology.[6] It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003.[7] It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA.[8]
The ICR occupies sites in Chelsea, Central London and Sutton, southwest London. The ICR provides both taught postgraduate degree programmes and research degrees and currently has around 340 students. Together with the Royal Marsden Hospital the ICR forms the largest comprehensive cancer centre in Europe,[9] and was ranked second amongst all British higher education institutions in the Times Higher Education's assessment of the 2021 Research Excellence Framework.[10] In clinical medicine, 97% and in biological sciences, 99% of the ICR's academic research was assessed to be world leading or internationally excellent (4* or 3*).[11]
The annual income of the institution for 2022–23 was £138.7 million of which £64.6 million was from research grants and contracts, with an expenditure of £134.9 million.[2] The ICR receives its external grant funding from the government body the Higher Education Funding Council for England, from government research council bodies and from charities including the Wellcome Trust, Cancer Research UK, Breast Cancer Now and Bloodwise. It also receives voluntary income from legacies and from public and corporate donations. The ICR also runs a number of fundraising appeals and campaigns which help support a variety of cancer research projects.[12]
- ^ "The Institute of Cancer Research Annual Report and Financial Statements 2011" (PDF). Institute of Cancer Research. Archived from the original (PDF) on 24 September 2015. Retrieved 13 April 2012.
- ^ a b c d e "Financial Statements for the Year to 31 July 2023" (PDF). Institute of Cancer Research. Retrieved 21 January 2024.
- ^ "ICR announces new Chair of Board of Trustees". Archived from the original on 16 January 2014. Retrieved 14 December 2021.
- ^ "ICR announces appointment of new Chief Executive". Retrieved 14 December 2021.
- ^ a b "Where do HE students study?". Higher Education Statistics Agency. Retrieved 1 March 2020.
- ^ "Ordinance 9: Member institutions of the University" (PDF). Lon.ac.uk. 29 March 2010. Retrieved 20 May 2021.
- ^ Cite error: The named reference
2009reviewwas invoked but never defined (see the help page). - ^ "Long-term Achievements". Institute of Cancer Research. Archived from the original on 24 November 2010. Retrieved 23 February 2011.
- ^ "Britain's best hospitals: A patients' guide". The Independent. 20 March 2008. Retrieved 20 October 2010.
- ^ "REF 2021: Quality ratings hit new high in expanded assessment". Times Higher Education. 12 May 2022.
- ^ "ICR rated second in UK among all higher education institutions in REF 2021 analysis". Institute of Cancer Research. Retrieved 12 May 2022.
- ^ "Our appeals and campaigns". Institute of Cancer Research. Retrieved 18 February 2016.
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search